Latest News

March 7, 2017: ACT-AD Urges Congress to Provide FDA with $2.8B in FY 2018

August 22, 2016: ACT-AD’s Bens Presents at PDUFA VI Public Meeting

June 8, 2016: Prospects Are Promising for Innovation Legislation

June 3, 2016: Senate Committee Acts on FY 2017 FDA Appropriations

April 19, 2016: NIH Launches Consortium to Study Vascular Links to AD

April 18, 2016: FDA Issues Draft Guidance Request on Neurological Devices

April 15, 2016: AHRQ Releases New Report on Dementia and Nonpharmacologic Interventions

March 31, 2016: Update on the Alzheimer’s Disease-Related Dementias 2016 Summit

March 3, 2016: Study Suggests Incidence of Dementia May Be on the Decline

February 22, 2016:  ACT-AD Welcomes New Member, APOE-ε4 .Info, Inc.

February 18, 2016:  ACT-AD a Media Partner for 10th Annual Drug Discovery for Neurodegeneration Conference

February 10, 2016: FDA Workshop to Gather Perspectives on Genetic Testing

January 19, 2016: Negative Beliefs about Aging Could Contribute to Development of Alzheimer’s Disease, Say Yale Experts

January 12, 2016: ACT-AD Executive Director Joins Panel on FDA and Patient Centeredness

January 5, 2016:  NIA Releases Alzheimer’s Disease Progress Report

December 22, 2015: December Update on PDUFA and MDUFA

December 12, 2015: NIH Starts Initiative on Alzheimer’s Disease and Down Syndrome

December 10, 2015: Conference on Alzheimer’s Disease-Related Dementias, March 29-30, 2016

December 4, 2015: Senate Committee Considers FDA Commissioner Nomination

September 16, 2015: Leading Experts Assess the Current State of Alzheimer’s Disease Therapeutic Development